Rejoyn
Commercial- Indications
- Major Depressive Disorder
Company intelligence / Profile preview
Click Therapeutics
New York City/New York County/Borough of Manhattan, New York, United Statesclicktherapeutics.com ↗
- Ownership
- Private
- Employees
- ~200
- Development stage
- Commercial
01
Overview
Click’s pivotal trial data show that CT–132 significantly reduced monthly migraine days versus control when used alongside standard-of-care medications. The company’s depression app Rejoyn™, developed with Otsuka, was the first prescription digital therapeutic authorized by the FDA as an adjunct to antidepressants. AspyreRx provides CBT-based support to adults with type II diabetes and was acquired from Better Therapeutics. Clinical results across programs demonstrate meaningful benefit in psychiatry, neurology, and cardiometabolic disease.
- Therapeutic areas
- EndocrinologyPsychiatryNeurology
- Modalities
- Prescription digital therapeutics (PDTs)Software-enhanced drug therapiesCognitive behavioral therapy (CBT) via digital platformsNeuromodulatory mechanisms of actionAI and machine learning-driven interventions
- Industry
- Digital Health Medical Devices
02
Drug pipeline
4 assets3 more assets in the full pipeline.
Request access →03
Partnerships
Otsuka Pharmaceutical Co., Ltd. (depression program)Boehringer Ingelheim (schizophrenia)Indivior PLC (opioid use disorder)Dassault Systèmes Medidata Solutions division—strategic investor/development partnerSanofi—historical investor/supporter
Beyond the preview
Go deeper on Click Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Click Therapeutics.